Tesamorelin is a synthetic peptide that prompts your body to produce more of its own growth hormone, and its best-documented benefit is reducing visceral fat — the deep abdominal fat that wraps around your organs. In clinical trials it lowered visceral fat by roughly 15% while helping preserve lean muscle, which is why it is used to improve body composition rather than simply lower the number on a scale. It is FDA-approved only for a specific HIV-associated condition; its use for general fat loss and body composition is off-label and should be physician-supervised. Here is what tesamorelin does, who it may suit, and the safety details that matter.
What is tesamorelin?
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue — a lab-made peptide that mimics the natural signal your body uses to release growth hormone. It is sold under the brand name Egrifta and was FDA-approved in 2010 to reduce excess abdominal fat in people with HIV-associated lipodystrophy. Outside that indication — for body composition, metabolic health, or anti-aging goals in people without HIV — its use is off-label, meaning a physician prescribes it at their discretion rather than under an FDA-approved use.
At Robertson Wellness and Aesthetics it is offered as part of physician-guided peptide therapy, as a compounded injectable prepared by a licensed pharmacy and provided only after a consultation. You can also review the specific tesamorelin peptide options we carry.
How does tesamorelin work? (mechanism of action)
Tesamorelin binds to GHRH receptors in the pituitary gland and stimulates it to release your body’s own growth hormone in a natural, pulsatile pattern. In plain terms, rather than injecting growth hormone directly, tesamorelin nudges your own gland to make more of it. That rise in growth hormone (and the downstream hormone IGF-1) promotes lipolysis — the breakdown of stored fat — with a notable effect on visceral fat, and supports protein synthesis that helps maintain lean tissue. This GHRH mechanism is described in the pivotal trials by Falutz et al. (New England Journal of Medicine, 2007).
Because it works with your own hormonal machinery instead of replacing it, tesamorelin is often described as a more physiologic approach than direct growth-hormone injections. It is not an anabolic steroid, and it does not raise testosterone.
Tesamorelin benefits for fat loss and body composition
The evidence for tesamorelin is strongest for body composition rather than overall weight. Reported and studied benefits include:
- Visceral fat reduction. This is the headline benefit. In randomized trials, tesamorelin reduced visceral adipose tissue by roughly 15% over about six months — the deep, metabolically active fat linked to higher cardiometabolic risk.
- Improved body composition. By raising growth hormone and supporting protein synthesis, tesamorelin favors fat loss while helping preserve lean muscle, which is why the scale may move less than a person expects even as the waistline changes.
- Reduced liver fat. Studies in the HIV-lipodystrophy population also showed reductions in liver fat, a marker of metabolic health (JAMA, 2014).
- Possible sleep and recovery effects. Because growth hormone and deep sleep are linked, some users report better sleep quality, though this is less rigorously established than the fat-loss data.
An important distinction: tesamorelin is not a general weight-loss drug. It targets visceral fat and body composition, which is different from the total-weight reduction seen with GLP-1 medications like semaglutide. That difference is exactly why some people pair or sequence these tools under medical guidance — a conversation that fits naturally within a medical weight management program.
✓ Consultation required
★★★★★
5.0 on Yelp · 35+ reviews
Interested in tesamorelin for visceral fat?
Tesamorelin is a prescription peptide that should follow a proper evaluation. Our Beverly Hills physicians
review your goals, labs, and history, then — if it fits — provide pharmaceutical-grade, compounded
tesamorelin with appropriate monitoring, alongside the rest of your body-composition plan.
These statements have not been evaluated by the FDA. Tesamorelin is FDA-approved only for HIV-associated
lipodystrophy; other uses are off-label and prescribed only after a medical evaluation by a licensed provider.
It is not appropriate for everyone. Compounded medications are not FDA-approved. Individual results vary.
Who is tesamorelin for — and who is it not for?
In a clinical setting, tesamorelin is generally considered for adults whose primary goal is reducing stubborn visceral (abdominal) fat and improving body composition, particularly when standard diet and exercise haven’t resolved deep abdominal fat, and when a physician has reviewed their labs and health history. It appeals to body-composition-focused and longevity-minded patients rather than people simply looking to drop total pounds.
It is not a first-line, self-prescribed product, and it is not appropriate for everyone. Tesamorelin should be avoided in people with active cancer (because growth hormone can influence cell growth), during pregnancy, and in those with certain pituitary conditions, and it warrants caution in people with diabetes or blood-sugar concerns because growth hormone can affect insulin sensitivity. A responsible approach includes comprehensive blood testing — including markers like IGF-1 and glucose — before and during therapy. For men weighing tesamorelin alongside hormone optimization, it often sits within a broader men’s health plan.
How is tesamorelin taken, and how fast does it work?
Tesamorelin is given as a small daily subcutaneous injection, typically at night to align with the body’s natural overnight growth-hormone release. Because dosing and reconstitution depend on the formulation and the individual, they should be set by the prescribing provider, not guessed from online sources. Results build gradually: changes in body composition typically emerge over weeks to a few months of consistent use, with visceral-fat effects in trials measured at around the six-month mark. Reputable care re-checks labs over time rather than promising a fixed result by a fixed date.
Tesamorelin side effects and safety
According to Mayo Clinic and the FDA prescribing information for Egrifta, the more common side effects of tesamorelin include:
- Injection-site reactions — redness, itching, pain, or irritation where it’s injected.
- Joint pain (arthralgia) and muscle aches.
- Swelling or fluid retention (edema) and, less commonly, tingling or numbness (paresthesia).
- Flushing and, occasionally, headache.
- Effects on blood sugar. Because it raises growth hormone and IGF-1, tesamorelin can influence insulin sensitivity, which is why glucose monitoring matters, especially in anyone with diabetes or prediabetes.
It is contraindicated in pregnancy, in people with active malignancy, and in those with disruption of the hypothalamic-pituitary axis. This is precisely why tesamorelin should be prescribed and monitored by a licensed provider rather than sourced from unregulated “research” sellers of unknown purity or sterility. Legitimate care means pharmaceutical-grade product from a compliant pharmacy under the supervision of a licensed clinical team.
Tesamorelin vs. CJC-1295 and other growth-hormone peptides
Tesamorelin is one of several peptides that work on the growth-hormone axis, and they are not interchangeable. Tesamorelin is a GHRH analogue with the strongest clinical evidence specifically for visceral-fat reduction. CJC-1295 is also a long-acting GHRH analogue but is often combined with ipamorelin (a ghrelin-receptor peptide) for broader growth-hormone support and recovery goals. Which peptide — if any — fits depends on your objective, labs, and a physician’s assessment. For a detailed side-by-side, see our comparison of tesamorelin and CJC-1295.
Medical Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Tesamorelin is FDA-approved only for the reduction of excess abdominal fat in HIV-associated lipodystrophy; other uses, including general body composition and fat loss, are off-label. It must be prescribed and supervised by a licensed healthcare provider following an individual evaluation, is not appropriate for everyone, and carries contraindications including active cancer and pregnancy. Compounded medications are not FDA-approved, and the FDA does not verify the safety or effectiveness of compounded drugs. Individual results may vary. Always consult a qualified healthcare provider before beginning any new treatment.
Frequently asked questions
What does tesamorelin do?
Tesamorelin stimulates your pituitary gland to release more of your own growth hormone, which promotes the breakdown of fat — especially visceral (deep abdominal) fat — and supports lean muscle. Its best-documented effect is reducing visceral fat and improving body composition.
Will tesamorelin get rid of belly fat?
In clinical trials, tesamorelin reduced visceral fat — the deep fat around the organs that contributes to a larger waistline — by roughly 15% over about six months. It specifically targets that deep abdominal fat rather than subcutaneous “pinchable” fat, and results depend on the individual, dosing, and consistent use under medical supervision.
Is tesamorelin similar to Ozempic?
No. They work differently and target different things. Ozempic (semaglutide) is a GLP-1 medication that reduces appetite and overall body weight. Tesamorelin is a GHRH peptide that specifically targets visceral fat and body composition, not total weight. Some people consider them for different goals, which is a discussion for a physician.
Is tesamorelin a steroid?
No. Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue — a peptide that signals your body to make its own growth hormone. It is not an anabolic steroid and does not raise testosterone.
How long does tesamorelin take to work?
Changes in body composition typically develop over weeks to a few months of consistent daily use, with visceral-fat effects in trials assessed at around six months. Onset and degree of response vary between individuals, and progress should be tracked with follow-up labs.
Is tesamorelin safe?
When prescribed and monitored by a licensed provider in an appropriate candidate, tesamorelin is generally tolerated, with injection-site reactions, joint pain, swelling, and effects on blood sugar among the reported side effects. It is contraindicated in pregnancy and active cancer and warrants caution in diabetes. Safety depends on proper screening, correct dosing, and medical supervision — not on buying peptides online.
Talk to a physician before starting tesamorelin
If reducing visceral fat and improving body composition is your goal, the most useful first step is a consultation and bloodwork — not an online purchase. Robertson Wellness and Aesthetics offers physician-supervised peptide therapy in Beverly Hills, with in-clinic and concierge options. Book a consultation to find out whether tesamorelin — or another approach — fits your goals, your labs, and your health history.
